1 terminated. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Terminated 1 |
Follow Endotoxemia: new trials by email Literature Review of Endotoxemia trials Research Report on Endotoxemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rifaximin in Cirrhosis: Effects on Endotoxin and Haemostatic Indexes Rifaximin, Placebo - Liver Cirrhosis, Coagulation Disorder | Phase 4 | Terminated | University of Roma La Sapienza | 20 | 2021-04-03 | 2024-10-08 |
Blood Platelet Disorders (1) · Hemostatic Disorders (1) · Liver Cirrhosis (1)
Bacteremia (1) · Cardiovascular Diseases (1) · Digestive System Diseases (1) · Fibrosis (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Infections (1) · Inflammation (1) · Liver Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Sepsis (1) · Systemic Inflammatory Response Syndrome (1) · Toxemia (1)
Rifaximin (1)
University of Roma La Sapienza (1)
Italy (1)
Lucia Stefanini, Prof. (1) · Manuela Merli, Prof. (1) · Oliviero Riggio, Prof. (1) · Roberto Carnevale, Prof. (1)